Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Afya ( (AFYA) ) has provided an update.
Afya Limited reported its financial results for the first quarter of 2025, showcasing significant growth in revenue and profitability. The company achieved a 16.4% year-over-year increase in net revenue, reaching R$936.4 million, and a 23.7% rise in adjusted EBITDA, with a margin expansion to 52.5%. The results were driven by successful student intake processes, strategic acquisitions, and operational efficiencies. Afya also announced the acquisition of Faculdade Masterclass Ltda., expanding its presence in Belo Horizonte, and received significant credit rating upgrades, reflecting its strong financial performance and leadership in medical education.
Spark’s Take on AFYA Stock
According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.
Afya demonstrates strong financial performance with robust revenue and profitability growth, and solid cash flow metrics. Technical indicators suggest positive short-term momentum, although a lack of comprehensive technical analysis data and low dividend yield slightly temper the overall score. The stock is well-valued, appealing to growth-focused investors.
To see Spark’s full report on AFYA stock, click here.
More about Afya
Afya Limited is a leading medical education group and provider of medical practice solutions in Brazil. The company focuses on offering an integrated ecosystem of education and medical practice solutions throughout the entire medical journey, supporting healthcare professionals’ development and productivity.
Average Trading Volume: 106,962
Technical Sentiment Signal: Buy
Current Market Cap: $1.72B
See more insights into AFYA stock on TipRanks’ Stock Analysis page.